SIMPLEX TRADING, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$25
-44.4%
703
-60.6%
0.00%
Q1 2023$45
-100.0%
1,786
-44.6%
0.00%
Q3 2022$106,000
-7.8%
3,222
-1.5%
0.00%
Q2 2022$115,000
-1.7%
3,270
+28.3%
0.00%
Q1 2022$117,000
-92.3%
2,548
-88.9%
0.00%
-100.0%
Q4 2021$1,518,000
-44.7%
22,902
-29.1%
0.00%
-33.3%
Q3 2021$2,745,000
+18.8%
32,311
+15.8%
0.00%
+50.0%
Q2 2021$2,310,00027,896
-9.6%
0.00%
Q1 2021$0
-100.0%
30,850
+17.2%
0.00%
-100.0%
Q4 2020$2,018,000
+8.0%
26,313
-39.4%
0.00%0.0%
Q3 2020$1,869,000
-0.8%
43,414
-0.5%
0.00%0.0%
Q2 2020$1,885,000
+42.6%
43,654
-5.1%
0.00%
+50.0%
Q1 2020$1,322,000
-17.7%
45,984
+81.5%
0.00%
-50.0%
Q4 2019$1,607,000
+78.0%
25,339
-21.0%
0.00%
+33.3%
Q3 2019$903,000
-27.4%
32,069
-31.7%
0.00%0.0%
Q2 2019$1,244,000
+667.9%
46,978
+429.3%
0.00%
Q1 2019$162,000
+16.5%
8,876
-21.0%
0.00%
Q4 2018$139,000
+4.5%
11,231
+61.0%
0.00%
Q3 2018$133,000
-83.7%
6,974
-88.4%
0.00%
-100.0%
Q2 2018$818,000
+976.3%
60,189
+467.1%
0.00%0.0%
Q1 2018$76,000
-30.9%
10,613
-29.3%
0.00%
-57.1%
Q3 2016$110,000
+266.7%
15,003
+161.3%
0.01%
+250.0%
Q2 2016$30,0005,7420.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders